Raymond E. Moellering

Raymond E. Moellering

Auto-generated profile, based on publicly available information

Raymond E. Moellering

Department of Chemistry The University of Chicago Chicago Illinois USA

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 November 2009 in Nature
Verified
Journal Article
Closed access
PDF file
RMRaymond E. Moellering
Raymond E. Moellering
MCMelanie Gisela Cornejo
Melanie Gisela Cornejo
TDTina N. Davis
Tina N. Davis
CBCristina Del Bianco
Cristina Del Bianco
JAJon C. Aster
Jon C. Aster
JBJames E. Bradner
James E. Bradner

1 May 2019 in Nature
Verified
Journal Article
Closed access
PDF file
MEMark Eckert
Mark Eckert
FCFabian Coscia
Fabian Coscia
ACAgnieszka Chryplewicz
Agnieszka Chryplewicz
JCJae Won Chang
Jae Won Chang
KHKyle M. Hernandez
Kyle M. Hernandez
ELErnst Lengyel
Ernst Lengyel

15 October 2018 in Nature
Verified
Journal Article
Closed access
PDF file
MBMichael J. Bollong
Michael J. Bollong
GLGihoon Lee
Gihoon Lee
JCJohn S. Coukos
John S. Coukos
HYHwayoung Yun
Hwayoung Yun
CZClaudio Zambaldo
Claudio Zambaldo
RMRaymond E. Moellering
Raymond E. Moellering

15 October 2012 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
TGTom N Grossmann
Tom N Grossmann
JYJohannes T.-H. Yeh
Johannes T.-H. Yeh
BBBrian R. Bowman
Brian R. Bowman
QCQian Chu
Qian Chu
RMRaymond E. Moellering
Raymond E. Moellering
GVGregory L. Verdine
Gregory L. Verdine
Aberrant activation of signaling by the Wnt pathway is strongly implicated in the onset and progression of numerous types of cancer. Owing to the persistent dependence of these tumors on Wnt signaling for growth and survival, inhibition of this pathway is considered an attractive mechanism-based therapeutic approach. Oncogenic activation of Wnt signaling can ensue from a variety of distinct aberrations in the signaling pathway, but most share the common feature of causing increased cellular levels of β-catenin by interfering with its constitutive degradation. β-Catenin serves as a central hub in Wnt signaling by engaging in crucial protein–protein interactions with both negative and positive effectors of the pathway. Direct interference with these protein–protein interactions is a biologically compelling approach toward suppression of β-catenin hyperactivity, but such interactions have proven intransigent with respect to small-molecule targeting. Hence β-catenin remains an elusive target for translational cancer therapy. Here we report the discovery of a hydrocarbon-stapled peptide that directly targets β-catenin and interferes with its ability to serve as a transcriptional coactivator for T-cell factor (TCF) proteins, the downstream transcriptional regulators of the Wnt pathway.

14 October 2014 in MedChemComm
Verified
Journal Article
Closed access
PDF file
QCQian Chu
Qian Chu
RMRaymond E. Moellering
Raymond E. Moellering
GHGerard J. Hilinski
Gerard J. Hilinski
YKYoung-Woo Kim
Young-Woo Kim
TGTom N Grossmann
Tom N Grossmann
GVGregory L. Verdine
Gregory L. Verdine
A systematic study on cell penetration by stapled peptides.

2 August 2013 in Science
Verified
Journal Article
Closed access
RMRaymond E. Moellering
Raymond E. Moellering
BCBenjamin F. Cravatt
Benjamin F. Cravatt
Modification Without Enzymes: Control of metabolic enzymes and regulation of many other biological processes is mediated in large part by binding of small molecules to proteins or through enzymatically medimediated covalent posttranslational modification of proteins. Moellering and Cravatt (p. 549 ) wondered whether another scenario might occur in which reactive intermediates in a metabolic pathway might specifically react with and modify particular amino acids in proteins to produce regulatory changes without the need for catalysis by another enzyme. A particularly reactive intermediate formed during glycolysis, 1,3-bisphosphoglycerate, could nonenzymatically modify specific lysines in proteins, providing a means by which accumulation of metabolic intermediates could provide regulatory feedback to balance or control flux through various pathways. Proteomic analysis showed that the 3-phosphoglyceryl-lysine formed when certain lysine residues interacted with 1,3-bisphosphoglycerate produced naturally in cells and was particularly common in proteins that function in glycolysis. Such modification decreased activity of the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase.